200 related articles for article (PubMed ID: 18776043)
1. The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche.
Aicher A; Kollet O; Heeschen C; Liebner S; Urbich C; Ihling C; Orlandi A; Lapidot T; Zeiher AM; Dimmeler S
Circ Res; 2008 Oct; 103(8):796-803. PubMed ID: 18776043
[TBL] [Abstract][Full Text] [Related]
2. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.
Kollet O; Dar A; Shivtiel S; Kalinkovich A; Lapid K; Sztainberg Y; Tesio M; Samstein RM; Goichberg P; Spiegel A; Elson A; Lapidot T
Nat Med; 2006 Jun; 12(6):657-64. PubMed ID: 16715089
[TBL] [Abstract][Full Text] [Related]
3. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells.
van der Horst G; van der Werf SM; Farih-Sips H; van Bezooijen RL; Löwik CW; Karperien M
J Bone Miner Res; 2005 Oct; 20(10):1867-77. PubMed ID: 16160745
[TBL] [Abstract][Full Text] [Related]
5. CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules.
Shivtiel S; Kollet O; Lapid K; Schajnovitz A; Goichberg P; Kalinkovich A; Shezen E; Tesio M; Netzer N; Petit I; Sharir A; Lapidot T
J Exp Med; 2008 Sep; 205(10):2381-95. PubMed ID: 18779349
[TBL] [Abstract][Full Text] [Related]
6. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
Sankar U; Patel K; Rosol TJ; Ostrowski MC
J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF.
Fujita K; Janz S
Mol Cancer; 2007 Oct; 6():71. PubMed ID: 17971207
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte Colony-Stimulating Factor Induces Osteoblast Inhibition by B Lymphocytes and Osteoclast Activation by T Lymphocytes during Hematopoietic Stem/Progenitor Cell Mobilization.
Li S; Li T; Chen Y; Nie Y; Li C; Liu L; Li Q; Qiu L
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1384-91. PubMed ID: 25985917
[TBL] [Abstract][Full Text] [Related]
9. Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice.
Rao M; Supakorndej T; Schmidt AP; Link DC
Exp Hematol; 2015 Feb; 43(2):110-4.e1-2. PubMed ID: 25461255
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs.
Winkler IG; Sims NA; Pettit AR; Barbier V; Nowlan B; Helwani F; Poulton IJ; van Rooijen N; Alexander KA; Raggatt LJ; Lévesque JP
Blood; 2010 Dec; 116(23):4815-28. PubMed ID: 20713966
[TBL] [Abstract][Full Text] [Related]
11. Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.
Herbert BA; Valerio MS; Gaestel M; Kirkwood KL
PLoS One; 2015; 10(5):e0125387. PubMed ID: 25946081
[TBL] [Abstract][Full Text] [Related]
12. Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization.
Miyamoto K; Yoshida S; Kawasumi M; Hashimoto K; Kimura T; Sato Y; Kobayashi T; Miyauchi Y; Hoshi H; Iwasaki R; Miyamoto H; Hao W; Morioka H; Chiba K; Kobayashi T; Yasuda H; Penninger JM; Toyama Y; Suda T; Miyamoto T
J Exp Med; 2011 Oct; 208(11):2175-81. PubMed ID: 22006978
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo.
Chiusaroli R; Knobler H; Luxenburg C; Sanjay A; Granot-Attas S; Tiran Z; Miyazaki T; Harmelin A; Baron R; Elson A
Mol Biol Cell; 2004 Jan; 15(1):234-44. PubMed ID: 14528021
[TBL] [Abstract][Full Text] [Related]
14. The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potential.
Smadja DM; d'Audigier C; Weiswald LB; Badoual C; Dangles-Marie V; Mauge L; Evrard S; Laurendeau I; Lallemand F; Germain S; Grelac F; Dizier B; Vidaud M; Bièche I; Gaussem P
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2544-52. PubMed ID: 20847303
[TBL] [Abstract][Full Text] [Related]
15. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow.
Gregory CA; Singh H; Perry AS; Prockop DJ
J Biol Chem; 2003 Jul; 278(30):28067-78. PubMed ID: 12740383
[TBL] [Abstract][Full Text] [Related]
16. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
17. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization.
Steinmetz M; Pelster B; Lucanus E; Arnal JF; Nickenig G; Werner N
J Mol Cell Cardiol; 2013 Apr; 57():32-42. PubMed ID: 23295770
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
20. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
